California Healthcare Institute Political Action Committee (CHIPAC)
A - OTH
$712.9K
Total received
319
Donations
102
Unique contributors
$2.2K
Avg donation
Years active: 2014, 2013, 2012
Top Contributions
| Date | Contributor | Type | Amount |
|---|---|---|---|
| Nov 7, 2014 | Allergan | OTH | $7,000 |
| Nov 7, 2014 | Allergan | OTH | $7,000 |
| Feb 11, 2014 | Medtronic, Inc. | OTH | $6,800 |
| Dec 18, 2014 | Edwards Lifesciences | OTH | $6,800 |
| Feb 11, 2014 | Thermo Fisher Scientific, Inc. | OTH | $6,800 |
| Jan 29, 2014 | Gilead Sciences, Inc. | OTH | $6,800 |
| Feb 11, 2014 | Medtronic, Inc. | OTH | $6,800 |
| Nov 7, 2014 | Boston Scientific | OTH | $6,800 |
| Jan 28, 2014 | Allergan | OTH | $6,800 |
| May 28, 2013 | Amgen | OTH | $6,800 |
| Mar 11, 2014 | Amgen | OTH | $6,800 |
| Jan 29, 2014 | Gilead Sciences, Inc. | OTH | $6,800 |
| Nov 26, 2013 | Edwards Lifesciences | OTH | $6,800 |
| Jan 28, 2014 | Allergan | OTH | $6,800 |
| Mar 4, 2014 | PricewaterhouseCoopers | OTH | $6,800 |
| Jan 7, 2014 | Theravance, Inc | OTH | $6,800 |
| Jan 7, 2014 | St. Jude Medical | OTH | $6,800 |
| Jan 7, 2014 | St. Jude Medical | OTH | $6,800 |
| Nov 7, 2014 | Boston Scientific | OTH | $6,800 |
| May 28, 2013 | Amgen | OTH | $6,800 |
| Dec 18, 2014 | Edwards Lifesciences | OTH | $6,800 |
| May 16, 2013 | Pfizer, Inc | OTH | $6,800 |
| May 16, 2013 | Pfizer, Inc | OTH | $6,800 |
| Jun 20, 2014 | AstraZeneca | OTH | $6,800 |
| Mar 11, 2014 | Amgen | OTH | $6,800 |
| Apr 26, 2013 | Johnson & Johnson | OTH | $6,800 |
| Jan 7, 2014 | Theravance, Inc | OTH | $6,800 |
| Mar 4, 2014 | PricewaterhouseCoopers | OTH | $6,800 |
| Feb 18, 2014 | Genentech, Inc. | OTH | $6,800 |
| Feb 18, 2014 | Genentech, Inc. | OTH | $6,800 |
| Apr 26, 2013 | Johnson & Johnson | OTH | $6,800 |
| Dec 31, 2013 | Boston Scientific | OTH | $6,800 |
| Feb 11, 2014 | Thermo Fisher Scientific, Inc. | OTH | $6,800 |
| Jul 1, 2014 | Abbott Diabetes Care | OTH | $6,800 |
| Jul 15, 2014 | Pfizer, Inc | OTH | $6,800 |
| Jan 15, 2013 | Hologic+Genprobe | OTH | $6,500 |
| Jan 24, 2012 | Thermo Fisher Scientific, Inc. | OTH | $6,500 |
| Jan 31, 2012 | Allergan | OTH | $6,500 |
| Dec 26, 2012 | St. Jude Medical | OTH | $6,500 |
| Jan 4, 2012 | Edwards Lifesciences | OTH | $6,500 |
| Jan 24, 2012 | Gilead Sciences, Inc. | OTH | $6,500 |
| Jan 24, 2012 | Thermo Fisher Scientific, Inc. | OTH | $6,500 |
| Jan 31, 2012 | Allergan | OTH | $6,500 |
| Jan 31, 2012 | BD Biosciences | OTH | $6,500 |
| Nov 20, 2012 | Genentech, Inc. | OTH | $6,500 |
| Jan 31, 2012 | Genentech | OTH | $6,500 |
| Nov 20, 2012 | BD Biosciences | OTH | $6,500 |
| Nov 20, 2012 | Edwards Lifesciences | OTH | $6,500 |
| Nov 20, 2012 | Genentech, Inc. | OTH | $6,500 |
| Dec 26, 2012 | St. Jude Medical | OTH | $6,500 |
| Nov 20, 2012 | Edwards Lifesciences | OTH | $6,500 |
| Jan 31, 2012 | Gen-Probe Incorporated | OTH | $6,500 |
| Feb 28, 2012 | Johnson & Johnson Services, Inc. | OTH | $6,500 |
| Mar 6, 2012 | Amylin Pharmaceuticals | OTH | $6,500 |
| Jan 31, 2012 | BD Biosciences | OTH | $6,500 |
| Jan 22, 2013 | Medtronic, Inc. | OTH | $6,500 |
| Jan 22, 2013 | Thermo Fisher Scientific, Inc. | OTH | $6,500 |
| Jan 29, 2013 | Allergan | OTH | $6,500 |
| Jan 31, 2012 | Genentech | OTH | $6,500 |
| Jan 31, 2012 | Gen-Probe Incorporated | OTH | $6,500 |
| May 29, 2013 | Abbott Laboratories Employee PAC | COM | $6,500 |
| Jan 3, 2012 | St. Jude Medical | OTH | $6,500 |
| Jan 22, 2013 | Gilead Sciences, Inc. | OTH | $6,500 |
| Feb 28, 2012 | Johnson & Johnson Services, Inc. | OTH | $6,500 |
| Jan 3, 2012 | St. Jude Medical | OTH | $6,500 |
| Jan 4, 2012 | Edwards Lifesciences | OTH | $6,500 |
| Jan 29, 2013 | Allergan | OTH | $6,500 |
| Jan 22, 2013 | Thermo Fisher Scientific, Inc. | OTH | $6,500 |
| Jan 22, 2013 | Gilead Sciences, Inc. | OTH | $6,500 |
| Jan 15, 2013 | Hologic+Gen-Probe | OTH | $6,500 |
| Jan 24, 2012 | Gilead Sciences, Inc. | OTH | $6,500 |
| May 29, 2013 | Abbott Laboratories Employee PAC | COM | $6,500 |
| Jan 22, 2013 | Medtronic, Inc. | OTH | $6,500 |
| Nov 20, 2012 | BD Biosciences | OTH | $6,500 |
| Jul 23, 2013 | Hologic+Genprobe | OTH | $6,200 |
| Jan 15, 2013 | NuVasive, Inc. | OTH | $5,000 |
| Jan 15, 2013 | NuVasive, Inc. | OTH | $5,000 |
| Dec 26, 2014 | St. Jude Medical | OTH | $4,000 |
| Jul 1, 2014 | Astellas Pharmaceuticals | OTH | $4,000 |
| Dec 26, 2014 | St. Jude Medical | OTH | $4,000 |
| Jun 11, 2012 | Pfizer, Inc | OTH | $3,500 |
| Jun 11, 2012 | Pfizer, Inc | OTH | $3,500 |
| Jun 11, 2014 | Biogen Idec | OTH | $3,500 |
| Mar 12, 2013 | Merck & Company | OTH | $3,150 |
| Mar 25, 2014 | Boehringer - Ingelheim Pharmaceuticals, Inc. | OTH | $3,150 |
| Mar 25, 2014 | Boehringer - Ingelheim Pharmaceuticals, Inc. | OTH | $3,150 |
| Mar 12, 2013 | Merck & Company | OTH | $3,150 |
| Feb 25, 2013 | Boehringer - Ingelheim Pharmaceuticals, Inc. | OTH | $3,150 |
| Feb 25, 2013 | Boehringer - Ingelheim Pharmaceuticals, Inc. | OTH | $3,150 |
| Apr 3, 2012 | Pfizer, Inc | OTH | $3,000 |
| Apr 3, 2012 | Pfizer, Inc | OTH | $3,000 |
| Feb 7, 2012 | Boehringer - Ingelheim Pharmaceuticals, Inc. | OTH | $3,000 |
| Feb 7, 2012 | Boehringer - Ingelheim Pharmaceuticals, Inc. | OTH | $3,000 |
| Dec 17, 2014 | Align Technology, Inc. | OTH | $2,888 |
| Jan 7, 2014 | Align Technology, Inc. | OTH | $2,888 |
| Jan 7, 2014 | Align Technology, Inc. | OTH | $2,888 |
| Dec 17, 2014 | Align Technology, Inc. | OTH | $2,888 |
| Mar 18, 2014 | Daiichi Sankyo, Inc. | OTH | $2,887.5 |
| Feb 5, 2013 | Daiichi Sankyo, Inc. | OTH | $2,887.5 |
| Mar 18, 2014 | Daiichi Sankyo, Inc. | OTH | $2,887.5 |
| Feb 5, 2013 | Daiichi Sankyo, Inc. | OTH | $2,887.5 |
| Mar 5, 2013 | Takeda Pharmaceuticals | OTH | $2,750 |
| Mar 27, 2012 | Takeda Pharmaceuticals | OTH | $2,750 |
| Mar 27, 2012 | Takeda Pharmaceuticals | OTH | $2,750 |
| Mar 5, 2013 | Takeda Pharmaceuticals | OTH | $2,750 |
| Apr 15, 2014 | Jazz Pharmaceuticals, Inc. | OTH | $2,363 |
| Apr 15, 2014 | Jazz Pharmaceuticals, Inc. | OTH | $2,363 |
| Nov 7, 2014 | NuVasive, Inc. | OTH | $2,250 |
| Nov 7, 2014 | NuVasive, Inc. | OTH | $2,250 |
| Feb 18, 2014 | Agensys, Inc. | OTH | $2,000 |
| Feb 18, 2014 | Agensys, Inc. | OTH | $2,000 |
| Nov 20, 2012 | Align Technology, Inc. | OTH | $1,943 |
| Nov 20, 2012 | Onyx Pharmaceuticals, Inc. | OTH | $1,943 |
| Jan 15, 2013 | BioMarin | OTH | $1,943 |
| Dec 17, 2014 | BioMarin | OTH | $1,943 |
| Jan 15, 2013 | BioMarin | OTH | $1,943 |
| Nov 26, 2013 | BioMarin | OTH | $1,943 |
| Dec 17, 2014 | BioMarin | OTH | $1,943 |
| Nov 20, 2012 | Onyx Pharmaceuticals, Inc. | OTH | $1,943 |
| Nov 20, 2012 | Align Technology, Inc. | OTH | $1,943 |
| Jan 31, 2012 | Align Technology, Inc. | OTH | $1,850 |
| Jan 31, 2012 | Align Technology, Inc. | OTH | $1,850 |
| Dec 23, 2013 | NuVasive, Inc. | OTH | $1,800 |
| Nov 14, 2014 | Ted Lieu for Senate 2014 | COM | $1,500 |
| Nov 14, 2014 | Ted Lieu for Senate 2014 | COM | $1,500 |
| Nov 5, 2013 | Genomic Health, Inc. | OTH | $1,496 |
| Jan 17, 2012 | Onyx Pharmaceuticals, Inc. | OTH | $1,425 |
| Jan 17, 2012 | Onyx Pharmaceuticals, Inc. | OTH | $1,425 |
| Apr 10, 2012 | Zimmer | OTH | $1,213 |
| Apr 10, 2012 | Zimmer | OTH | $1,213 |
| May 20, 2014 | Medivation | OTH | $1,076 |
| Dec 26, 2012 | Genomic Health, Inc. | OTH | $1,076 |
| Dec 26, 2012 | Genomic Health, Inc. | OTH | $1,076 |
| Apr 9, 2013 | Medivation | OTH | $1,076 |
| Apr 9, 2013 | Medivation | OTH | $1,076 |
| Jan 24, 2012 | ISTA Pharmaceuticals | OTH | $1,025 |
| Jan 24, 2012 | ISTA Pharmaceuticals | OTH | $1,025 |
| Apr 15, 2014 | Chandler Chicco Agency | OTH | $1,025 |
| Jan 17, 2012 | Alphatec Spine | OTH | $1,025 |
| Jan 3, 2012 | Quidel Corporation | OTH | $1,025 |
| Jan 3, 2012 | Genomic Health, Inc. | OTH | $1,025 |
| Jun 26, 2012 | Affymax, Inc. | OTH | $1,025 |
| Jun 26, 2012 | Affymax, Inc. | OTH | $1,025 |
| Apr 15, 2014 | Chandler Chicco Agency | OTH | $1,025 |
| Jan 17, 2012 | Alphatec Spine | OTH | $1,025 |
| Jan 3, 2012 | Quidel Corporation | OTH | $1,025 |
| Jan 3, 2012 | Genomic Health, Inc. | OTH | $1,025 |
| Feb 18, 2014 | Genentech, Inc. | OTH | $1,010 |
| Feb 18, 2014 | Genentech, Inc. | OTH | $1,010 |
| Jul 29, 2014 | Mendelson, Alan C.Latham & Watkins | IND | $1,000 |
| Oct 23, 2014 | Versant Ventures | OTH | $1,000 |
| Oct 23, 2014 | Versant Ventures | OTH | $1,000 |
| Nov 20, 2012 | OncoMed Pharmaceuticals | OTH | $849 |
| Nov 20, 2012 | OncoMed Pharmaceuticals | OTH | $849 |
| Jan 2, 2013 | DexCom | OTH | $683 |
| May 13, 2014 | MicroVention | OTH | $683 |
| Jan 2, 2013 | DexCom | OTH | $683 |
| Dec 26, 2012 | NEKTAR Therapeutics | OTH | $683 |
| Dec 26, 2012 | NEKTAR Therapeutics | OTH | $683 |
| Jan 14, 2014 | NEKTAR Therapeutics | OTH | $683 |
| Jan 14, 2014 | NEKTAR Therapeutics | OTH | $683 |
| May 13, 2014 | MicroVention | OTH | $683 |
| Nov 14, 2014 | Ted Lieu for Senate 2014 | COM | $654.36 |
| Nov 14, 2014 | Ted Lieu for Senate 2014 | COM | $654.36 |
| Apr 3, 2012 | NEKTAR Therapeutics | OTH | $650 |
| Jan 9, 2014 | Shire Regenerative Medicine, Inc. | OTH | $650 |
| Apr 3, 2012 | NEKTAR Therapeutics | OTH | $650 |
| Jan 9, 2014 | Shire Regenerative Medicine, Inc. | OTH | $650 |
| Dec 4, 2012 | Shire Regenerative Medicine, Inc. | OTH | $650 |
| Dec 4, 2012 | Shire Regenerative Medicine, Inc. | OTH | $650 |
| Nov 6, 2014 | Shire Pharmaceuticals | OTH | $630 |
| Oct 18, 2014 | TechNet California Political Action Committee | COM | $531.76 |
| Oct 18, 2014 | TechNet California Political Action Committee | COM | $531.76 |
| Oct 18, 2014 | TechNet California Political Action Committee | COM | $531.76 |
| Feb 11, 2014 | KPMG LLP | OTH | $525 |
| Jul 23, 2013 | Latham & Watkins | OTH | $525 |
| Dec 26, 2012 | Hogan Lovells | OTH | $525 |
| Jan 22, 2013 | KPMG LLP | OTH | $525 |
| Mar 13, 2013 | Aptiv Solutions | OTH | $525 |
| Mar 13, 2013 | Aptiv Solutions | OTH | $525 |
| Jan 22, 2013 | KPMG LLP | OTH | $525 |
| Mar 4, 2014 | Wilson Sonsini Goodrich & Rosati | OTH | $525 |
| Feb 11, 2014 | KPMG LLP | OTH | $525 |
| Mar 4, 2014 | Wilson Sonsini Goodrich & Rosati | OTH | $525 |
| Mar 4, 2014 | Alexandria Real Estate Equities | OTH | $525 |
| Mar 4, 2014 | Alexandria Real Estate Equities | OTH | $525 |
| Dec 26, 2012 | Hogan Lovells | OTH | $525 |
| Oct 23, 2014 | Sidley Austin LLP | OTH | $525 |
| Oct 23, 2014 | Sidley Austin LLP | OTH | $525 |
| Jan 28, 2014 | Allergan | OTH | $510 |
| Jan 28, 2014 | Allergan | OTH | $510 |
| Feb 6, 2012 | KPMG | OTH | $500 |
| Jan 2, 2013 | Nusil Technology | OTH | $500 |
| Apr 2, 2013 | Sidley Austin LLP | OTH | $500 |
| Apr 10, 2012 | Fish & Richardson | OTH | $500 |
| Feb 21, 2012 | Sidley Austin LLP | OTH | $500 |
| Mar 4, 2014 | Mead, DanaKleiner Perkins Caufield & Byers | IND | $500 |
| Jan 2, 2013 | Nusil Technology | OTH | $500 |
| Feb 21, 2012 | Sidley Austin LLP | OTH | $500 |
| Apr 10, 2012 | Fish & Richardson | OTH | $500 |
| Feb 6, 2012 | KPMG | OTH | $500 |
| Apr 2, 2013 | Sidley Austin LLP | OTH | $500 |
| May 6, 2014 | Heart Metabolics | OTH | $500 |
| Mar 6, 2012 | Hogan Lovells | OTH | $500 |
| Mar 4, 2014 | Mead, DanaKleiner Perkins Caufield & Byers | IND | $500 |
| Dec 23, 2013 | NuVasive, Inc. | OTH | $450 |
| Jul 23, 2013 | Hologic+Genprobe | OTH | $300 |
| Jan 14, 2014 | Arena Pharmaceuticals | OTH | $289 |
| Jan 7, 2014 | Exelixis, Inc. | OTH | $289 |
| Oct 15, 2013 | Sequenom | OTH | $289 |
| Oct 9, 2014 | Exelixis, Inc. | OTH | $289 |
| Oct 10, 2014 | Sequenom | OTH | $289 |
| Oct 10, 2014 | Sequenom | OTH | $289 |
| Oct 10, 2014 | Sequenom | OTH | $289 |
| Jan 14, 2014 | Arena Pharmaceuticals | OTH | $289 |
| Aug 5, 2014 | Vivus, Inc. | OTH | $289 |
| Jan 7, 2014 | Exelixis, Inc. | OTH | $289 |
| Jan 3, 2012 | DexCom Inc | OTH | $275 |
| Apr 3, 2012 | Spectrum Pharmaceuticals | OTH | $275 |
| Jan 3, 2012 | DexCom Inc | OTH | $275 |
| Dec 4, 2012 | BN ImmunoTherapeutics | OTH | $275 |
| Apr 3, 2012 | Spectrum Pharmaceuticals | OTH | $275 |
| Dec 4, 2012 | BN ImmunoTherapeutics | OTH | $275 |
| Dec 11, 2012 | ExploraMed | OTH | $260 |
| Dec 11, 2012 | ExploraMed | OTH | $260 |
| Jan 6, 2014 | Versant Ventures | OTH | $257 |
| Jan 6, 2014 | Versant Ventures | OTH | $257 |
| Feb 21, 2014 | Synarc | OTH | $250 |
| Jan 14, 2014 | Intercare Insurance Solutions | OTH | $250 |
| Jan 14, 2014 | Intercare Insurance Solutions | OTH | $250 |
| Apr 22, 2014 | Organogenesis, Inc. | OTH | $250 |
| Dec 11, 2012 | ACIST Medical | OTH | $250 |
| Dec 11, 2012 | ACIST Medical | OTH | $250 |
| Dec 17, 2014 | Intercare Insurance Solutions | OTH | $250 |
| Jan 22, 2013 | Intercare Insurance Solutions | OTH | $250 |
| Feb 26, 2013 | Synarc | OTH | $250 |
| Jan 22, 2013 | Intercare Insurance Solutions | OTH | $250 |
| Apr 22, 2014 | Organogenesis, Inc. | OTH | $250 |
| Dec 16, 2013 | ACIST Medical | OTH | $250 |
| Dec 17, 2014 | Intercare Insurance Solutions | OTH | $250 |
| Feb 26, 2013 | Synarc | OTH | $250 |
| Feb 21, 2014 | Synarc | OTH | $250 |
| Jan 2, 2013 | Exelixis, Inc. | OTH | $208 |
| Jan 2, 2013 | Exelixis, Inc. | OTH | $208 |
| Dec 18, 2014 | Edwards Lifesciences | OTH | $200 |
| Apr 10, 2012 | Exelixis, Inc. | OTH | $200 |
| Dec 18, 2014 | Edwards Lifesciences | OTH | $200 |
| Apr 10, 2012 | Exelixis, Inc. | OTH | $200 |
| Nov 7, 2014 | Boston Scientific | OTH | $200 |
| Nov 7, 2014 | Boston Scientific | OTH | $200 |
| Jan 22, 2013 | Arena Pharmaceuticals | OTH | $195 |
| Jan 22, 2013 | Arena Pharmaceuticals | OTH | $195 |
| Feb 28, 2012 | Arena Pharmaceuticals | OTH | $185 |
| Feb 28, 2012 | Arena Pharmaceuticals | OTH | $185 |
| Nov 20, 2014 | Mike McGuire for State Senate 2014 | COM | $177.29 |
| Nov 20, 2014 | Mike McGuire for State Senate 2014 | COM | $177.29 |
| Aug 14, 2012 | Geron Corporation | OTH | $163 |
| Jul 1, 2014 | Hyperion Therapeutics | OTH | $151 |
| Apr 1, 2013 | XOMA | OTH | $150 |
| Nov 26, 2013 | XOMA | OTH | $150 |
| Apr 1, 2013 | XOMA | OTH | $150 |
| Oct 23, 2014 | Rigel Pharmaceuticals, Inc | OTH | $135.5 |
| Oct 23, 2014 | Rigel Pharmaceuticals, Inc | OTH | $135.5 |
| Jan 3, 2012 | CODAN US Corporation | OTH | $133 |
| Jan 3, 2012 | CODAN US Corporation | OTH | $133 |
| Nov 26, 2013 | Strathspey Crown LLC | OTH | $131 |
| Dec 26, 2012 | Experien Group | OTH | $131 |
| Oct 1, 2014 | Moss Adams LLP | OTH | $131 |
| Apr 23, 2013 | SOAProjects | OTH | $131 |
| Apr 23, 2013 | SOAProjects | OTH | $131 |
| Oct 1, 2014 | Moss Adams LLP | OTH | $131 |
| Dec 26, 2012 | Experien Group | OTH | $131 |
| Jul 29, 2014 | SOAProjects, Inc. | OTH | $131 |
| Oct 1, 2014 | Moss Adams LLP | OTH | $131 |
| Aug 19, 2013 | CFI Medical Solutions | OTH | $131 |
| Dec 23, 2013 | Rigel Pharmaceuticals, Inc | OTH | $130 |
| Dec 4, 2012 | Rigel Pharmaceuticals, Inc | OTH | $130 |
| Dec 4, 2012 | Rigel Pharmaceuticals, Inc | OTH | $130 |
| Aug 13, 2012 | Strathspey Crown LLC | OTH | $125 |
| Dec 23, 2013 | CODAN US Corporation | OTH | $117 |
| Jan 2, 2013 | CODAN US Corporation | OTH | $117 |
| Jan 2, 2013 | CODAN US Corporation | OTH | $117 |
| Dec 31, 2014 | Achaogen | OTH | $50 |
| Nov 20, 2012 | NeuroPace | OTH | $50 |
| Nov 29, 2012 | Achaogen | OTH | $50 |
| Nov 20, 2012 | The Foundry LLC | OTH | $50 |
| Dec 26, 2012 | CardioDx, Inc. | OTH | $50 |
| Jan 29, 2013 | Prima BioMed | OTH | $50 |
| Nov 20, 2012 | Tandem Diabetes Care, Inc | OTH | $50 |
| Nov 20, 2012 | Sangart, Inc. | OTH | $50 |
| Nov 20, 2012 | Organovo, Inc. | OTH | $50 |
| Jan 29, 2013 | Prima BioMed | OTH | $50 |
| Dec 17, 2014 | Orexigen Therapeutics, Inc. | OTH | $50 |
| Feb 13, 2013 | Aradigm Corporation | OTH | $50 |
| Nov 20, 2012 | NeuroPace | OTH | $50 |
| Oct 24, 2012 | OptiMedica | OTH | $50 |
| Dec 31, 2014 | Achaogen | OTH | $50 |
| Feb 13, 2013 | Aradigm Corporation | OTH | $50 |
| Oct 10, 2014 | Ground Zero Pharmaceuticals, Inc. | OTH | $50 |
| Dec 23, 2013 | Sangamo BioSciences, Inc | OTH | $50 |
| Oct 23, 2014 | Organovo, Inc. | OTH | $50 |
| Oct 10, 2014 | Ground Zero Pharmaceuticals, Inc. | OTH | $50 |
| Dec 23, 2013 | Aradigm Corporation | OTH | $50 |
| Nov 29, 2012 | Achaogen | OTH | $50 |
| Nov 20, 2012 | The Foundry LLC | OTH | $50 |
| Nov 20, 2012 | Tandem Diabetes Care, Inc | OTH | $50 |
| Nov 20, 2012 | Sangart, Inc. | OTH | $50 |
| Dec 11, 2012 | Orexigen Therapeutics, Inc. | OTH | $50 |
| Jan 29, 2013 | Prima BioMed | OTH | $50 |
| Oct 24, 2012 | OptiMedica | OTH | $50 |
| Nov 20, 2012 | Organovo, Inc. | OTH | $50 |
| Dec 11, 2012 | Orexigen Therapeutics, Inc. | OTH | $50 |
| Dec 26, 2012 | CardioDx, Inc. | OTH | $50 |
| Oct 23, 2014 | Organovo, Inc. | OTH | $50 |
| Jan 29, 2013 | Prima BioMed | OTH | $50 |
| Dec 17, 2014 | Orexigen Therapeutics, Inc. | OTH | $50 |
| Oct 10, 2014 | Ground Zero Pharmaceuticals, Inc. | OTH | $50 |
| Feb 13, 2013 | Aradigm Corporation | OTH | $50 |
| Feb 13, 2013 | Aradigm Corporation | OTH | $50 |